Cargando…

Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience

Detalles Bibliográficos
Autores principales:	Lin, Li-Ching, Huang, Wen-Kuan, Yen, Chueh-Chuan, Yang, Ching-Yao, Sung, Meng-Ta, Wong, Natalie S.M., Chua, Daniel T. T., Lee, Sarah W. M., Chen, Jen-Shi, Yeh, Chun-Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612116/ https://www.ncbi.nlm.nih.gov/pubmed/36313668 http://dx.doi.org/10.3389/fonc.2022.1028118

Ejemplares similares

Compassionate Use of Ripretinib for Patients With Metastatic Gastrointestinal Stromal Tumors: Taiwan and Hong Kong Experience
por: Lin, Li-Ching, et al.
Publicado: (2022)

Ripretinib for gastrointestinal stromal tumours
Publicado: (2021)

Ripretinib for the treatment of advanced gastrointestinal stromal tumor
por: Zalcberg, John R.
Publicado: (2021)

Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward
por: Lostes-Bardaji, M. Julia, et al.
Publicado: (2021)

Emerging Data on the Safety and Efficacy of Ripretinib for the Treatment of Gastrointestinal Stromal Tumors
por: Thirasastr, Prapassorn, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Fourth- or Further-Line Ripretinib in Advanced Gastrointestinal Stromal Tumors
por: Liao, Weiting, et al.
Publicado: (2021)

Management of Patients With Advanced Gastrointestinal Stromal Tumor: Emphasis on Fourth-Line Treatment With Ripretinib
por: Brackert, Sandra, et al.
Publicado: (2023)

China, Hong Kong and Taiwan, Health Systems of
por: Leung, G.M., et al.
Publicado: (2008)

Ripretinib: First Approval
por: Dhillon, Sohita
Publicado: (2020)

Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib
por: Janku, Filip, et al.
Publicado: (2020)

Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study
por: Zalcberg, John R., et al.
Publicado: (2021)

Efficacy and safety of ripretinib in Chinese patients with advanced gastrointestinal stromal tumors: a real-world, multicenter, observational study
por: Yang, Weili, et al.
Publicado: (2023)

Correction to: Ripretinib: First Approval
por: Dhillon, Sohita
Publicado: (2020)

Clinical practice guidelines for patients with gastrointestinal stromal tumor in Taiwan
por: Yeh, Chun-Nan, et al.
Publicado: (2012)

The Progress of Emergency Medicine in Taiwan, China, and Hong Kong: Perspective from Publications in Emergency Medicine Journals, 1992–2011
por: Lee, Ching-Hsing, et al.
Publicado: (2014)

A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan
por: Lau, Eric HY, et al.
Publicado: (2010)

Work Values of University Students in Chinese Mainland, Taiwan, and Hong Kong
por: Wong, Shui Wai, et al.
Publicado: (2012)

Are Hong Kong and Taiwan stepping‐stones for invasive species to the mainland of China?
por: Lu, Jianbo, et al.
Publicado: (2018)

Democratising qualitative research methods: Reflections on Hong Kong, Taiwan and China
por: Sik Ying Ho, Petula, et al.
Publicado: (2018)

Genotyping guided ripretinib directly after the progression of first-line imatinib therapy in advanced gastrointestinal stromal tumor: a case report
por: Huang, Shaoqing, et al.
Publicado: (2022)

Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study
por: Bauer, Sebastian, et al.
Publicado: (2021)

Index Patient and SARS Outbreak in Hong Kong
por: Wong, Raymond S.M., et al.
Publicado: (2004)

Attitudes toward and beliefs about obese persons across Hong Kong and Taiwan: wording effects and measurement invariance
por: Tsai, Meng-Che, et al.
Publicado: (2019)

Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery
por: Gouda, Mohamed A., et al.
Publicado: (2023)

Cultural sociology in East Asia: three trajectories in Hong Kong, Taiwan and Korea
por: Ku, Agnes Shuk-mei, et al.
Publicado: (2021)

A comparative perspective on COVID-19 stress levels in Hong Kong and Taiwan
por: Wei, Lien-Chung
Publicado: (2023)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique [Corrigendum]
Publicado: (2023)

Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial
por: Schöffski, Patrick, et al.
Publicado: (2022)

Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial
por: Bauer, Sebastian, et al.
Publicado: (2022)

Ripretinib in combination with tyrosine kinase inhibitor as a late-line treatment option for refractory gastrointestinal stromal tumors: two case reports and literature review
por: Zhang, Yefan, et al.
Publicado: (2023)

Plants of Hong Kong /
por: Thrower, S. L.
Publicado: (1971)

Hospital in Hong Kong
Publicado: (1892)

Melioidosis in Hong Kong
por: Lui, Grace, et al.
Publicado: (2018)

Hong Kong Medical Journal – the Premier General Medical Journal in Hong Kong
por: Li, Kenneth KW, et al.
Publicado: (2021)

Cesarean section in China, Taiwan, and Hong Kong—A safe choice for women and clinicians?
por: Black, Mairead, et al.
Publicado: (2018)

The Use of hx-index to compare research achievements for ophthalmology authors in Mainland China, Hong Kong, and Taiwan since 2010
por: Yeh, Yu-Tsen, et al.
Publicado: (2021)

Power and endurance in Hong Kong professional football players
por: Chan, Hardaway Chun-Kwan, et al.
Publicado: (2016)

The Hong Kong Infection Control Nurses’ Association – the key to success
por: Chan, RFY, et al.
Publicado: (2015)

Role of PLK1 signaling pathway genes in gastrointestinal stromal tumors
por: Chen, Jen-Shi, et al.
Publicado: (2018)

Evolution and Control of COVID-19 Epidemic in Hong Kong
por: Wong, Shuk-Ching, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fe0b0glelsoovul65p5dkimgjt